1.Previous
3.Next

undergo machine perfusion prior to transplantation. To date, the majority of evidence supporting FMN as a surrogate marker of transplant outcome derives from liver grafts assessed during hypothermic machine perfusion (HOPE), prior to transplantation. Here, FMN concentrations were measured in perfusate during HOPE, either by sampling perfusate every 30 minutes and performing a

1.Previous
3.Next